Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta
Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta: A Randomized Clinical Trial
Sponsors |
Lead Sponsor: Ain Shams University |
---|---|
Source | Ain Shams University |
Brief Summary | 40 pregnant females at term diagnosed with morbidly adherent placenta and planned for elective cesarean section were recruited and randomized to 2 groups. Group A: Internal iliac ligation followed by cesarean hysterectomy. Group B: cesarean hysterectomy. |
Overall Status | Completed | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Start Date | 2017-03-01 | ||||||||||
Completion Date | 2020-07-02 | ||||||||||
Primary Completion Date | 2020-01-01 | ||||||||||
Phase | Phase 3 | ||||||||||
Study Type | Interventional | ||||||||||
Primary Outcome |
|
||||||||||
Secondary Outcome |
|
||||||||||
Enrollment | 40 |
Condition | |
---|---|
Intervention |
Intervention Type: Procedure Intervention Name: Internal iliac artery ligation Description: Internal iliac artery ligation and cesarean hysterectomy Arm Group Label: internal iliac artery ligation + cesarean hysterectomy Other Name: cesarean hysterectomy Intervention Type: Procedure Intervention Name: cesarean hysterectomy Description: cesarean hysterectomy |
Eligibility |
Criteria:
Inclusion Criteria: - Placenta previa accreta - Previous 2 cesarean section - completed her family - Hemoglobin > 11 gm/dl - Elective cesarean hysterectomy Exclusion Criteria: - Anemia ( Hemoglobin < 11 gm/dl) - Not completed her family - BMI > 35 Kg/m2 - Bleeding tendency - Emergengy cesarean section - Thrombophilia Gender: Female Minimum Age: 25 Years Maximum Age: 40 Years Healthy Volunteers: No |
Overall Contact | Contact information is only displayed when the study is recruiting subjects. | ||
---|---|---|---|
Location |
|
Location Countries |
Egypt |
---|---|
Verification Date |
2020-07-01 |
Responsible Party |
Type: Principal Investigator Investigator Affiliation: Ain Shams University Investigator Full Name: Mohamed S Sweed, MD Investigator Title: Principal Investigator |
Keywords | |
Has Expanded Access | No |
Condition Browse | |
Number Of Arms | 2 |
Arm Group |
Label: internal iliac artery ligation + cesarean hysterectomy Type: Active Comparator Label: cesarean hysterectomy Type: Active Comparator |
Patient Data | No |
Study Design Info |
Allocation: Randomized Intervention Model: Parallel Assignment Primary Purpose: Prevention Masking: None (Open Label) |
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Loss
-
NCT03249038CompletedConditions: Blood Loss, Surgical, Blood Loss, Blood Loss, Postoperative
-
NCT03824873CompletedConditions: Blood Loss
-
NCT02864095Unknown statusConditions: Blood Loss
-
NCT02860221Unknown statusConditions: Blood Loss
-
NCT03867214Unknown statusConditions: Blood Loss
-
NCT01331499TerminatedConditions: Blood Loss
-
NCT01014728CompletedConditions: Blood Loss
-
NCT00792597CompletedConditions: Blood Loss
-
NCT01472913CompletedConditions: Blood Loss
-
NCT01604668CompletedConditions: Blood Loss
Clinical Trials on Internal iliac artery ligation
-
NCT03824873CompletedConditions: Blood Loss
-
NCT03129035Unknown statusConditions: Placenta Accreta
-
NCT02728232CompletedConditions: Placenta Percreta
-
NCT04593303CompletedConditions: Placenta Accreta
-
NCT05471102RecruitingConditions: Placenta Accreta